(Q39854307)

15 September 2017

Multiple catalytic aldolase antibodies suitable for chemical programming (English)

1 reference

15 September 2017

1 reference

Rajib Kumar Goswami

1

1 reference

15 September 2017

Zheng-Zheng Huang

2

1 reference

15 September 2017

Jane S Forsyth

3

1 reference

15 September 2017

Brunhilde Felding-Habermann

4

1 reference

15 September 2017

Subhash C Sinha

5

1 reference

15 September 2017

language of work or name

English

0 references

publication date

18 April 2009

1 reference

Bioorganic & Medicinal Chemistry Letters

15 September 2017

1 reference

15 September 2017

19

1 reference

15 September 2017

14

1 reference

15 September 2017

3821-3824

1 reference

Beta-lactam-based approach for the chemical programming of aldolase antibody 38C2

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

Breaking the one antibody-one target axiom

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

Chemical adaptor immunotherapy: design, synthesis, and evaluation of novel integrin-targeting devices.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalyst.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

A cofactor approach to copper-dependent catalytic antibodies

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

Using antibody catalysis to study the outcome of multiple evolutionary trials of a chemical task

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

Aldol sensors for the rapid generation of tunable fluorescence by antibody catalysis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

Immune versus natural selection: antibody aldolases with enzymic rates but broader scope

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

Integrins alpha v beta 3 and alpha v beta 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

Involvement of integrin alpha V gene expression in human melanoma tumorigenicity

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

Preparation of integrin alpha(v)beta3-targeting Ab 38C2 constructs.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

Chemically programmed antibodies: endothelin receptor targeting CovX-Bodies.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

The origin of enantioselectivity in aldolase antibodies: crystal structure, site-directed mutagenesis, and computational analysis

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923540

Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19428247

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Broadening the Aldolase Catalytic Antibody Repertoire by Combining Reactive Immunization and Transition State Theory: New Enantio- and Diastereoselectivities

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19428247

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.BMCL.2009.04.041

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

19428247

1 reference